← Back to Search

Brain Stimulation + Behavioral Training for Peripheral Nerve Injury

N/A
Recruiting
Led By Scott H Frey, Ph.D., Ed.M.
Research Sponsored by University of Missouri-Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Individuals who have undergone repairs of the median, ulnar, or other related or nearby nerve(s) following complex volar forearm lacerations or other injuries between the distal wrist crease and the flexor musculotendinous junctions. Individuals must be at the chronic stage of recovery (approx. 12 - 18 months following surgery, when Tinel's sign reaches the distal fingertips)
Be older than 18 years old
Must not have
Individuals with a history of seizures or unexplained loss of consciousness
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, immediately after end of intervention (+/- 3 days).
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a brain stimulation technique to help improve recovery after nerve injuries in hands and arms. It combines behavioral training with electric stimulation.

Who is the study for?
This trial is for people who've had certain hand surgeries like transplants or nerve repairs and are in the later stages of recovery (about a year to a year and a half post-surgery). It's not for those with severe brain injuries, serious mental health issues, chronic neurological conditions, pregnancy, seizure history, or specific implants.
What is being tested?
The study tests if combining behavior training with non-invasive brain stimulation called tDCS can help the brain adapt better after hand surgery. Participants will undergo Transcranial Direct Current Stimulation along with Modified Constraint Induced Movement Therapy.
What are the potential side effects?
tDCS may cause mild side effects such as itching, tingling at the stimulation site, headache, fatigue or nausea. However, it's generally considered safe and these sensations typically fade shortly after treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I had surgery for a severe forearm cut and it's been 12-18 months since.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had seizures or unexplained fainting episodes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, immediately after end of intervention (+/- 3 days).
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, immediately after end of intervention (+/- 3 days). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from Baseline Dellon Modified Moberg Pick-Up Test performance at two weeks.
Secondary study objectives
Change from Baseline Action Research Arm Test (ARAT) performance at two weeks.
Change from baseline upper limb movement as measured by actigraphy-derived variables during everyday life at periodic intervals after intervention.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Active Control
Group I: Transplantation/Replantation PatientsActive Control2 Interventions
Can plateaued hand function in hand transplantation patients/hand replantation patients in the chronic stage of recovery be facilitated by use of bi-hemispheric transcranial direct current stimulation (tDCS) combined with modified Constraint Induced Movement Therapy (CIMT)?
Group II: Actigraphy TestingActive Control1 Intervention
We will acquire a set of actigraphy data from a group of hand transplant/replant patients and unilateral, adult amputees in order to evaluate typical patterns of limb use prior to hand transplantation and to investigate prosthesis utilization.
Group III: Nerve Injury Patients activeActive Control2 Interventions
Can plateaued hand function in peripheral nervous system injuries in the chronic stage of recovery be facilitated by use of bi-hemispheric transcranial direct current stimulation (tDCS) combined with modified Constraint Induced Movement Therapy (CIMT)?

Find a Location

Who is running the clinical trial?

University of Missouri-ColumbiaLead Sponsor
379 Previous Clinical Trials
628,314 Total Patients Enrolled
Christine M. Kleinert Institute for Hand and MicrosurgeryOTHER
10 Previous Clinical Trials
785 Total Patients Enrolled
Washington University School of MedicineOTHER
1,991 Previous Clinical Trials
2,295,680 Total Patients Enrolled

Media Library

Modified Constraint Induced Movement Therapy Clinical Trial Eligibility Overview. Trial Name: NCT03610763 — N/A
Peripheral Nerve Injury Research Study Groups: Transplantation/Replantation Patients, Actigraphy Testing, Nerve Injury Patients active
Peripheral Nerve Injury Clinical Trial 2023: Modified Constraint Induced Movement Therapy Highlights & Side Effects. Trial Name: NCT03610763 — N/A
Modified Constraint Induced Movement Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT03610763 — N/A
~13 spots leftby Jun 2025